Find a TenderAwarded without competition

Published 11 Feb 2026, 12:12 GMT

Official UK procurement notice

NP90425 Faricimab (Vabysmo®) · UK public procurement notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)

Framework agreementGoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)

Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue

Awarded 25 Feb 2026no call for competition

What is being bought

Published requirement description

Supply of Faricimab (Vabysmo®) to NHSScotland.

CPV: Pharmaceutical products

How this framework works

From the published notice

Bids received: 1 bids received · 1 suppliers appointed

The lotProcurement structure

single lot · no lot value published

Lot #1The Framework Agreement is for the supply of Faricimab (Vabysmo®) to NHSScotlandAwarded

The Framework Agreement is for the supply of Faricimab (Vabysmo®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework Agreement to one (1) Framework Participant.

Delivery: Scotland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 11 Feb 2026, 12:12 GMT
Last source update: 24 Mar 2026, 08:56 GMT
FTS notice number: 2026/S 000-026580
Classification (CPV): Pharmaceutical products
Delivery area: Scotland (UKM)
Official registry OCID: ocds-h6vhtk-064dbd Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

Review and risk notes

Review procedure: The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement.
The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer.
The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages

Publisher note: The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month contract duration and the three (3) x twelve (12) month extension periods of the Framework Agreement. (SC Ref:826685)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Suppliers appointed 1admitted to the panel · see the list ↓

Bids received 1

Contracts signed 2latest 25 Feb 2026

2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 2 of these contracts carry the same published figure, £48,357,375, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

Contract 026580-2026-NP90425-1
Signed
25 Feb 2026
Value
ceiling above
Status
active
Contract 012346-2026-NP90425-1
Signed
11 Feb 2026
Value
ceiling above
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids · 1 electronic · 1 from abroad	0	—	—

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact email, phone

Dispute resolution & review bodies

Sheriff Court HouseReview body EdinburghContact email, phone

Framework contractors & participating bidders

1 commercial party on the notice

Roche Products LtdFramework contractor 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TWContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.